This study is currently not recruiting participants.

Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat Atrial Fibrillation

Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat Atrial Fibrillation
Not Recruiting
18 years - 80 years
All
Phase N/A
1 Location

Brief description of study

The purpose of the study is to provide data demonstrating the safety and effectiveness of the PulseSelect™ PFA System for the treatment of atrial fibrillation (AF)

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Atrial Fibrillation
  • Age: 18 years - 80 years
  • Gender: All

Male and Female Age 18-80 Atrial fibrillation, (AF)

Updated on 01 Aug 2024. Study ID: 848462

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center